In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

DUBLIN--(BUSINESS WIRE)--Research and Markets, the world's leading source for international market research reports and data, has seen a surge in demand for its services from pharmaceutical and ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Pharmaceutical companies are often lambasted for rising drug costs. For example, the price of new drugs entering the US market in 2023 was 35% higher than in 2022. According to an analysis from ...

India's pharmaceutical and healthcare industry is urging for increased support for research and development (R&D) in the forthcoming Union budget, as per an ET-PwC survey.

India, Jan. 28 -- Union Ministry of Health and Family Welfare has notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, in line with the directions of Hon'ble Prime Minister ...

Last year, Pirelli showed off its first 5G-connected Cyber Tyre. This year, it's taking that connectivity a step further. Artificial intelligence (AI) helped develop Pirelli's tires of the future, its ...